Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $724.26 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $392.16 | 5 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $185.75 | 2 | $0 (2020) |
| Alcon Puerto Rico Inc | $69.89 | 1 | $0 (2023) |
| Alcon Vision LLC | $51.93 | 1 | $0 (2024) |
| Shire North American Group Inc | $24.53 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51.93 | 1 | Alcon Vision LLC ($51.93) |
| 2023 | $69.89 | 1 | Alcon Puerto Rico Inc ($69.89) |
| 2020 | $132.92 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($85.75) |
| 2019 | $100.49 | 1 | Allergan Inc. ($100.49) |
| 2018 | $248.26 | 3 | Allergan Inc. ($148.26) |
| 2017 | $120.77 | 2 | Allergan Inc. ($96.24) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $51.93 | General |
| Category: Ophthalmology | ||||||
| 05/22/2023 | Alcon Puerto Rico Inc | Clareon (Device) | Food and Beverage | In-kind items and services | $69.89 | General |
| Category: Ophthalmology | ||||||
| 03/05/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $85.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/18/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $47.17 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $100.49 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/06/2018 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/06/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/06/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: OPTHALMICS | ||||||
| 03/18/2017 | Allergan Inc. | KYBELLA (Biological) | Food and Beverage | In-kind items and services | $96.24 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 54 | $3,987 | $2,671 |
| 2022 | 3 | 50 | 67 | $6,084 | $3,548 |
| 2021 | 5 | 86 | 103 | $8,210 | $5,114 |
| 2020 | 3 | 49 | 58 | $4,275 | $2,572 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 30 | 37 | $3,348 | $2,199 | 65.7% |
| 92250 | Photography of the retina | Office | 2023 | 17 | 17 | $639.37 | $471.84 | 73.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 23 | 40 | $3,569 | $2,105 | 59.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 13 | 13 | $1,984 | $1,084 | 54.6% |
| 92250 | Photography of the retina | Office | 2022 | 14 | 14 | $530.60 | $358.97 | 67.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 29 | 46 | $4,133 | $2,609 | 63.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 14 | 14 | $2,144 | $1,184 | 55.2% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 13 | 13 | $786.72 | $568.15 | 72.2% |
| 92250 | Photography of the retina | Office | 2021 | 17 | 17 | $679.49 | $447.72 | 65.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 13 | 13 | $466.15 | $305.36 | 65.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 25 | 34 | $3,070 | $1,744 | 56.8% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 11 | 11 | $710.49 | $515.67 | 72.6% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 13 | 13 | $494.91 | $312.54 | 63.2% |
About Dr. Enery Navarrete, M.D
Dr. Enery Navarrete, M.D is a Ophthalmology healthcare provider based in Humacao, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205991148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Enery Navarrete, M.D has received a total of $724.26 in payments from pharmaceutical and medical device companies, with $51.93 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($724.26).
As a Medicare-enrolled provider, Navarrete has provided services to 232 Medicare beneficiaries, totaling 282 services with total Medicare billing of $13,905. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Humacao, PR
- Active Since 12/22/2006
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205991148
Products in Payments
- LUMIGAN (Drug) $272.66
- Clareon (Device) $121.82
- VYZULTA (Drug) $100.00
- KYBELLA (Biological) $96.24
- LOTEMAX SM (Drug) $85.75
- XIIDRA (Drug) $24.53
- COMBIGAN (Drug) $23.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.